April - 2023
Showing Journal 4 of 5
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19
E Goligher, P Lawler, T Jensen et al JAMA, 2023, online first
This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register
No Comments yet.
The use of therapeutic-dose heparin in patients hospitalized for moderate or severe COVID-19 is of ongoing interest, with multiple RCTs reporting varied outcomes. In particular, the signal of benefit in non-critically ill hospitalised patients and no-benefit in critically ill patients,...